Shaker A. Mousa

33.5k total citations · 4 hit papers
665 papers, 24.6k citations indexed

About

Shaker A. Mousa is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shaker A. Mousa has authored 665 papers receiving a total of 24.6k indexed citations (citations by other indexed papers that have themselves been cited), including 214 papers in Molecular Biology, 124 papers in Hematology and 116 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shaker A. Mousa's work include Cell Adhesion Molecules Research (91 papers), Antiplatelet Therapy and Cardiovascular Diseases (74 papers) and Platelet Disorders and Treatments (73 papers). Shaker A. Mousa is often cited by papers focused on Cell Adhesion Molecules Research (91 papers), Antiplatelet Therapy and Cardiovascular Diseases (74 papers) and Platelet Disorders and Treatments (73 papers). Shaker A. Mousa collaborates with scholars based in United States, Egypt and Saudi Arabia. Shaker A. Mousa's co-authors include Paul J. Davis, Dhruba J. Bharali, Hung‐Yun Lin, Robert Block, Mehdi Rajabi, Faith B. Davis, Robert J. Linhardt, Thangirala Sudha, Ali H. El‐Far and Seema Mohamed and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Shaker A. Mousa

654 papers receiving 23.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non-small cell lung cancer: current treatment and future advances

2016 1.4k citations Shaker A. Mousa et al. profile →
Omega-3 Fatty Acids EPA and DHA: Health Benefits Throughout Life

2012 1.1k citations Robert Block, Shaker A. Mousa et al. profile →
Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin

2000 519 citations Shaker A. Mousa et al. profile →
The Role of Angiogenesis in Cancer Treatment

2017 502 citations Mehdi Rajabi, Shaker A. Mousa Biomedicines profile →

Peers

Countries citing papers authored by Shaker A. Mousa

Since Specialization

Citations

This map shows the geographic impact of Shaker A. Mousa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaker A. Mousa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaker A. Mousa more than expected).

Fields of papers citing papers by Shaker A. Mousa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaker A. Mousa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaker A. Mousa. The network helps show where Shaker A. Mousa may publish in the future.

Co-authorship network of co-authors of Shaker A. Mousa

This figure shows the co-authorship network connecting the top 25 collaborators of Shaker A. Mousa. A scholar is included among the top collaborators of Shaker A. Mousa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaker A. Mousa. Shaker A. Mousa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, characterization, and application of a poly(acrylic acid-co-acrylamide) cation exchanger (ACX) for camel lactoferrin purification 2025 ·International Journal of Biological Macromolecules ·(unknown), Marwa A. Ibrahim, Shaker A. Mousa, Fuming Zhang, Mohamad Warda	0
2	Discovery of novel thyrointegrin αvβ3 antagonist fb-PMT (NP751) in the management of human glioblastoma multiforme 2022 ·Neuro-Oncology Advances ·Kavitha Godugu, (unknown), Gennadi V. Glinsky, Shaker A. Mousa	0
3	Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells 2022 ·Metabolites ·Gennadi V. Glinsky, Kavitha Godugu, Thangirala Sudha, Mehdi Rajabi, Sridar V. Chittur, Aleck Hercbergs, Shaker A. Mousa, Paul J. Davis	4
4	Antitumor/Anti-Angiogenesis Efficacy of Epigallocatechin Gallate Nanoformulated with Antioxidant in Melanoma 2022 ·Nanomedicine ·Thangirala Sudha, Taher A. Salaheldin, Noureldien H. E. Darwish, Shaker A. Mousa	11
5	Mitochondria-targeted alginate/triphenylphosphonium-grafted-chitosan for treatment of hepatocellular carcinoma 2022 ·RSC Advances ·(unknown), Mohamed A. Hamzawy, Shaker A. Mousa, Ibrahim M. El‐Sherbiny	22
6	Genetic Interpretation of the Impacts of Honokiol and EGCG on Apoptotic and Self-Renewal Pathways in HEp-2 Human Laryngeal CD44^high Cancer Stem Cells 2021 ·Nutrition and Cancer ·(unknown), (unknown), (unknown), Osama A. Elkashty, (unknown), (unknown), Shaker A. Mousa	4
7	Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas 2021 ·Nutrition Research Reviews ·(unknown), (unknown), Robert Block, Shaker A. Mousa	2
8	Thymoquinone and its Nanoformulation Attenuate Colorectal and Breast Cancers and Alleviate Doxorubicin-Induced Cardiotoxicity 2021 ·Nanomedicine ·Ali H. El‐Far, Taher A. Salaheldin, Kavitha Godugu, Noureldien H. E. Darwish, Shaker A. Mousa	22
9	Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype&nbsp;4a in Human Hepatoma Cell Lines 2020 ·Dove Medical Press (Taylor and Francis Group) ·Samah A. Loutfy, (unknown), Khaled Y. Farroh, Hossam Taha Mohamed, (unknown), Mohamed Taha, Ahmed Hassan Ibrahim Faraag, Shaker A. Mousa	51
10	In Vitro Antifungal and Topical Anti-Inflammatory Properties of Essential Oil from Wild-Growing Thymus vulgaris (Lamiaceae) Used for Medicinal Purposes in Algeria: A New Source of Carvacrol 2020 ·Scientia Pharmaceutica ·Mohamed Nadjib Boukhatem, Noureldien H. E. Darwish, Thangirala Sudha, (unknown), (unknown), (unknown), (unknown), Mehdi Rajabi, (unknown), Shaker A. Mousa	28
11	Nongenomic Actions of Thyroid Hormone: The Integrin Component 2020 ·Physiological Reviews ·Paul J. Davis, Shaker A. Mousa, Hung‐Yun Lin	76
12	Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism 2020 ·Molecules ·Thikryat Neamatallah, Nagla A. El‐Shitany, Aymn T. Abbas, Basma G. Eid, Steve Harakeh, Soad Shaker Ali, Shaker A. Mousa	13
13	Contributions of Thyroid Hormone to Cancer Metastasis 2018 ·Biomedicines ·Shaker A. Mousa, Gennadi V. Glinsky, Hung‐Yun Lin, Osnat Ashur‐Fabian, Aleck Hercbergs, Kelly A. Keating, Paul J. Davis	38
14	Stem cells in the management of heart failure: what have we learned from clinical trials? 2014 ·Expert Review of Cardiovascular Therapy ·(unknown), (unknown), Shaker A. Mousa	3
15	Fibrin and Collagen Differentially but Synergistically Regulate Sprout Angiogenesis of Human Dermal Microvascular Endothelial Cells in 3-Dimensional Matrix 2013 ·International Journal of Cell Biology ·Xiaodong Feng, Marcia G. Tonnesen, Shaker A. Mousa, Richard A.F. Clark	70
16	The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome 2012 ·The Journal of Alternative and Complementary Medicine ·(unknown), Shaker A. Mousa	16
17	Biomarkers of Inflammation, Growth Factor, and Coagulation Activation in Patients With Sickle Cell Disease 2011 ·Clinical and Applied Thrombosis/Hemostasis ·Mohamad Qari, Usawadee Dier, Shaker A. Mousa	98
18	The Antiplatelet Activity of Camel Urine 2011 ·The Journal of Alternative and Complementary Medicine ·(unknown), Abdel Galil M. Abdel Gader, Shaker A. Mousa	32
19	Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects 2011 ·Cancers ·Dhruba J. Bharali, Imtiaz A. Siddiqui, Vaqar M. Adhami, Jean Christopher Chamcheu, Abdullah Aldahmash, Hasan Mukhtar, Shaker A. Mousa	78
20	Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate 2009 ·Cancer Research ·Imtiaz A. Siddiqui, Vaqar M. Adhami, Dhruba J. Bharali, Bilal Bin Hafeez, Mohammad Asim, Sabih I. Khwaja, Nihal Ahmad, Huadong Cui, Shaker A. Mousa, Hasan Mukhtar	281

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact